Regrettably, most of the analyzed laboratory parameters did not reach statistical significance in predicting response maintenance at the 52nd week of VDZ therapy.
← all excerpts
Real-world utility of platelet count, hemoglobin, and iron levels as predictors of clinical response to vedolizumab in patients with ulcerative colitis: a retrospective, single-center study in Poland.
1
—
—